Letter to the editor: The role of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in developing a COVID-19 comorbidity-based host risk score
Crossref DOI link:
Update policy: https://doi.org/10.1007/SPRINGER_CROSSMARK_POLICY
Vavougios, George D.
Text and Data Mining valid from 2020-05-19
Version of Record valid from 2020-05-19
1 April 2020
16 April 2020
19 May 2020
Ethics approval and consent to participate
Not applicable/single author.